Intelligence · Clinical Development
Pipeline search results
Programs matching “lansoprazole” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 32 pipeline programs matching "lansoprazole" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Dexlansoprazole
Takeda
Heartburn
1 trial -
Dexlansoprazole
Takeda
Erosive Esophagitis
2 trials -
Dexlansoprazole
Takeda
Gastroesophageal Reflux
2 trials -
Dexlansoprazole MR
Takeda
Esophagitis, Reflux
5 trials -
Dexlansoprazole MR
Takeda
Gastroesophageal Reflux Disease
4 trials -
Dexlansoprazole MR QD
Takeda
Gastroesophageal Reflux
1 trial -
Lansoprazole
Takeda
Stomach Ulcer
2 trials -
Lansoprazole and naproxen and aspirin
Takeda
Osteoarthritis
1 trial -
Lansoprazole microgranules suspension
Takeda
Gastroesophageal Reflux Disease
1 trial -
Dexlansoprazole
Takeda
Barrett's Esophagus
1 trial -
Dexlansoprazole
Takeda
Gastroesophageal Reflux Disease (GERD)
1 trial -
Lansoprazole
Takeda
Esophagitis
1 trial -
T2214
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gastric Diffuse Large B-cell Lymphoma
1 trial -
30 mg dexlansoprazole capsules manufactured at TOB
Takeda
Healthy Volunteers
2 trials -
Dexlansoprazole
Takeda
Healthy Volunteers
1 trial -
Dexlansoprazole
Takeda
Homeostasis
1 trial -
Dexlansoprazole
Takeda
Pediatric Gastroesophageal Reflux Disease
1 trial -
Dexlansoprazole Delayed Release Orally Disintegrating Tablets
Takeda
Bioavailability
1 trial -
Dexlansoprazole Injection
The First People's Hospital of Lianyungang
Effect of Drugs
1 trial -
Dexlansoprazole MR
Takeda
Gastroesophageal Reflux
1 trial -
Lansoprazole
Teva Pharma GmbH
Healthy
3 trials -
Lansoprazole
Takeda
Gastroesophageal Reflux Disease
2 trials -
Lansoprazole
PUMA BIOTECHNOLOGY, INC.
Healthy
1 trial -
Lansoprazole capsules
The First People's Hospital of Lianyungang
Effect of Drugs
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.